AI-based Frailty Assessment Tool for Patients Undergoing Cardiac Surgery

China National Center for Cardiovascular Diseases521 enrolled

Overview

The main purpose of this study is to establish a frailty automatic evaluation index "AI frailty index" based on artificial intelligence multi-modal non-contact monitoring information analysis. At the same time, the study will explore the correlation between ' AI weakness index ' and perioperative and long-term prognosis and quality of life.

This is a prospective cohort study. Patients who undergoes elective cardiac surgery will be enrolled. We collect frailty scales, clinical information and multi-modal, non-contact monitoring information during hospitalization. One-year follow-up will be done. The non-contact monitoring information are used to predict the frailty scales to establish and validate an AI-based frailty assessment model "AI frailty index". The AI frailty index will be further used to predict perioperative and long-term outcomes.

Study Type

OBSERVATIONAL

Enrollment

521

Conditions

Frailty

Interventions

No interventionOTHER

No intervention

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Elective cardiac surgery Exclusion Criteria: * Emergency surgery * Age ≤ 18 years * The clinical situation is unstable, such as frequent occurrence of coronary ischemia events, unstable heart failure, or acute events leading to severe discomfort symptoms or changes in vital signs * Unable to cooperate in completing research data collection due to severe neurological and psychiatric abnormalities or other reasons * Duration of postoperative ventilation \> 48 hours or inability to obtain scale data on the first day after surgery

Locations (1)

Fuwai hospital

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

One-dimensional matrix vector composed of five frailty scale results

Consisting of five frailty scales: Edmonton frailty scale, FRAIL frailty scale, Fried frailty scale, Clinical frailty scale, and SPPB

Time frame: Before and after surgery, up to 2 weeks

Secondary Outcomes

30-day adverse events

Including death, readmission, stroke, myocardial infarction, renal insufficiency or renal failure, dialysis, atrial fibrillation, peripheral vascular embolism, bleeding events, heart failure

Time frame: 30 days post operative

1-year adverse events

Including death, readmission, stroke, myocardial infarction, renal insufficiency or renal failure, dialysis, atrial fibrillation, peripheral vascular embolism, bleeding events, heart failure